Diane Janowicz is an Infectious Disease physician affiliated with St. Mary's Medical Center. OpenAlex indexes 44 publications with 951 citations (h-index 20).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
550 University Blvd
Indianapolis, IN 462025149
Telephone
317-944-5000Registry record last updated 5 Feb 2014.
Industry payments
1 company reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- Insmed, Inc.Program year20241 payment
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Anti-infectives
100%Cephalosporin Antibacterial29.6%Cefazolin Sodium68%Ceftriaxone32%Part D<11 patientsFirst-generation cephalosporins26.1%Cephalexin100%Part D≥27 patients+ 5 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
NIH funding
1 NIH research award on record, funded 2007–2011 per NIH RePORTER. The latest:
- Characterization of Lipoproteins in Haemophilus ducreyi Pathogenesis
Indiana University Indianapolis
FY2011$120,158K08AI074657 - Characterization of Lipoproteins in Haemophilus ducreyi Pathogenesis
Indiana University Indianapolis
FY2010$119,504K08AI074657 - Characterization of Lipoproteins in Haemophilus ducreyi Pathogenesis
Indiana University Indianapolis
FY2010$47,835K08AI074657
Awards in the NIH RePORTER records where a principal investigator name matches this physician at an organization in their practice state. Latest award years shown; each row links to the project record on RePORTER.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Class I Haemophilus ducreyi Strain Containing a Class II hgbA Allele Is Partially Attenuated in Humans: Implications for HgbA Vaccine Efficacy Trials2019
Similar KOLs
Other experts from the same institution or the same specialty.
William Ellinwood, MD
St. Mary's Medical Center
Damian Silbermins, MD
St. Mary's Medical Center
James Narrod, MD
St. Mary's Medical Center
Jeremy Anthony, MD
St. Mary's Medical Center
Yousef Khader
Jordan University of Science and Technology
Thomas Walsh, MD
Cornell University
Vance Fowler, MD
Duke University
Derrick W. Crook
Nuffield Orthopaedic Centre
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments, shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”